BUB 0.00% 13.5¢ bubs australia limited

Ann: Bubs US Growth Continues at Pace, page-19

  1. 4,128 Posts.
    lightbulb Created with Sketch. 1801
    FDA approval won't make a lick of difference if they aren't making any profit on the product and revenue growth tapers off.

    The US consumers purchasing the product don't care if it has temporary or permanent FDA approval. I doubt any would be even aware of the distinction.

    Don't get me wrong, it would be a major achievement to obtain the approval and it is not a given. But the reward for doing so is simply that they are able to continue doing business, irrespective of whether that business is profitable or not. The downside is that they will need to spend millions more between now and late 2025 in order to obtain the approval.
 
watchlist Created with Sketch. Add BUB (ASX) to my watchlist
(20min delay)
Last
13.5¢
Change
0.000(0.00%)
Mkt cap ! $120.4M
Open High Low Value Volume
13.5¢ 13.5¢ 13.0¢ $90.66K 685.2K

Buyers (Bids)

No. Vol. Price($)
43 3481808 13.0¢
 

Sellers (Offers)

Price($) Vol. No.
13.5¢ 817321 11
View Market Depth
Last trade - 16.10pm 25/07/2024 (20 minute delay) ?
BUB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.